1 / 19

Why a new PMB package? What’s wrong with what we have?

Why a new PMB package? What’s wrong with what we have?. Rajesh Patel BHF: Benefit & Risk May 2007. History. Oregan: methodology to prioritise and develop health insurance based on its Needs Demographics Burden of disease Soderland and Peprah

lois-nieves
Download Presentation

Why a new PMB package? What’s wrong with what we have?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Why a new PMB package?What’s wrong with what we have? Rajesh Patel BHF: Benefit & Risk May 2007

  2. History • Oregan: methodology to prioritise and develop health insurance based on its • Needs • Demographics • Burden of disease • Soderland and Peprah • Used methodology to propose core hospital benefit package • DOH/CMS: • List: in and outpatient • Address “dumping”

  3. Noble intentions • wayward implementation

  4. SA • Very different • Demographics • Health burden • HIV • Trauma • Economy …therefore need a different approach and different benefit design.

  5. SA private sector • CMS report – chronic disease prevalence • We do not have • Vital statistics • Health status data • Health burden data • Unrealised NEED! • Part of broader SA health system • Use WHO and MRC data for SA

  6. Will PMBs address this? • Health Charter – common basic benefit for all South Africans

  7. Catastrophic Health Cover • Driving policy framework for inclusion in current PMBs • Infertility, menopause, sec. amenorrhea,…pap smear and mammograms. • Origins in commercial insurance • Not in Health or Human development • Explicit, disease focused, individual focus, high cost-low frequency, emotive component • Not community/public focus • Not for community development

  8. Benefit Driven Essential Care (primary care focus) Individual patient first Insured Benefit Public health first Disease Driven Needs based benefit design Adapted from Stolk P et al. “Rare essentials”: drugs for rare diseases as essential medicine. WHO Bulletin: Sept 2006, 84 (9)

  9. Catastrophic Cover • Presupposes day to day care is adequately provided • Product of choice in developed economies • Oregon • Netherlands Small low income population, large middle income population • Is SA private sector a “developed” community? • Non randomised data • 28% of lives from families with member earning <R4500 • Is day to day cover adequately provided?

  10. Labour Force Survey, September 2006

  11. PMB • Predominantly referred care • NDOH promote primary care (June 94) Health benefit policy dichotomy • Disease and severity based • Fewer individuals with greater benefit depth • Not equitable benefit • Healthcare provision ≠ accessible

  12. PMB • Not explicit • Interpretation problems and conflict • “life threatening” • “…outpatient tests therefore its not a PMB” • “…only pay if appealed.” • physiotherapy: pneumonia for post-op physio • no minimum non-drug benefit defined • 5years later – no clarity • except for ICD10 list with its problems and BHF’s standardised guides • Scheme’s fault • Consider the “spirit”

  13. CDL • No public health policy or framework used to select diseases • Appears that most common conditions were used • Major depression and osteo-arthritis excluded • Expectation to cover other chronic conditions listed in DTP (patchwork design)

  14. CDL • Algorithms vs EDL • National alignment of process and benefit • Expectation of cover for biologics (RA & MS) • But no paracetamol (essential drug) for osteo-arthritis • Anomoly

  15. Benefit Driven Essential Care (primary care focus) Individual patient first Insured Benefit Public health first Disease Driven Needs based benefit design Adapted from Stolk P et al. “Rare essentials”: drugs for rare diseases as essential medicine. WHO Bulletin: Sept 2006, 84 (9)

  16. PMB • No adequate povision to address allocative inefficiency – “at cost” • it entrenches inefficiencies • Schemes blamed for not controlling cost • If LIMS is housed under the same act • How does one justify inequity of benefit in the context of HC developments • LIMS benefit must be core benefit of the PMB

  17. PMB • PMB implemented with no Health Impact Assessment program • How can be explain the value of R100+b spent to date • Survey of PMB cost estimate • R290-R390 PBPM • Current RETAP estimate R260 for smaller benefit than the Scheme risk

  18. Finally • Current PMB conceived in the 1990s • Many developments since then • LIMS • HC • MDG targets • National initiatives e.g. EDL, primary care, PPP • … These must be taken into account as we move towards SHI!

More Related